Arrowhead Pharmaceuticals (ARWR) Notes Payables (2010 - 2018)
Arrowhead Pharmaceuticals (ARWR) posted Notes Payables of $223820.0 for Q3 2018, up 1.79% on a QoQ basis from $219889.0 in Q2 2018, and up 7.34% year-over-year from $208506.0 in Q3 2017.
Arrowhead Pharmaceuticals (ARWR) Notes Payables (2010 - 2018) Analysis & Trends
Arrowhead Pharmaceuticals' Notes Payables history runs 9 years deep, the most recent figure standing at $223820.0 for Q3 2018.
- Quarterly Notes Payables rose 7.34% year-over-year to $223820.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $223820.0 (up 7.34% YoY) and the FY2018 annual result came in at $223820.0, up 7.34% from the prior year.
- Notes Payables was $223820.0 for Q3 2018 at Arrowhead Pharmaceuticals, up from $219889.0 in the prior quarter.
- Across five years, Notes Payables topped out at $4.9 million in Q1 2014 and bottomed at $50000.0 in Q2 2014.
- A 5-year average of $1.1 million and a median of $223820.0 in 2018 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2014 — Notes Payables slumped 97.86% — and 2015, when it surged 3348.94%.
- Arrowhead Pharmaceuticals' Notes Payables stood at $1.8 million in 2014, then dropped by 25.99% to $1.3 million in 2015, then plunged by 85.08% to $197713.0 in 2016, then advanced by 7.34% to $212233.0 in 2017, then rose by 5.46% to $223820.0 in 2018.
- Business Quant data shows ARWR's Notes Payables at $223820.0 in Q3 2018, $219889.0 in Q2 2018, and $216027.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 223,820.00 |
| Jun 30, 2018 | 219,889.00 |
| Mar 31, 2018 | 216,027.00 |
| Dec 31, 2017 | 212,233.00 |
| Sep 30, 2017 | 208,506.00 |
| Jun 30, 2017 | 83,113.00 |
| Mar 31, 2017 | 201,247.00 |
| Dec 31, 2016 | 197,713.00 |
| Sep 30, 2016 | 1.60 Mn |
| Jun 30, 2016 | 144,435.00 |
| Mar 31, 2016 | 955,193.00 |
| Dec 31, 2015 | 1.33 Mn |
| Sep 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 1.72 Mn |
| Mar 31, 2015 | 1.62 Mn |
| Dec 31, 2014 | 1.79 Mn |
| Sep 30, 2014 | 4.17 Mn |
| Jun 30, 2014 | 50,000.00 |
| Mar 31, 2014 | 4.94 Mn |
| Dec 31, 2013 | 5.10 Mn |